Vertex Pharmaceuticals is set to post its third-quarter results next month, and analysts project a single-digit earnings drop ...

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease — a ...

“Our pursuit of breakthrough science and serial innovation has changed the treatment landscape for cystic fibrosis ... the onset of end-stage kidney disease or death. The final study analysis will ...

The NHS has announced that newborns will be screened for a rare, life-threatening metabolic disorder that can lead to kidney ...

Now, it’s worth noting Stock Advisor's total average return is 1,061% — a market-crushing outperformance compared to 192% for ...

Today I got a text message from my general practice saying, ‘This is a reminder you are due your NHS Health Check’ with a link to the NHS site ...

Indeed, simple liver cysts are almost always asymptomatic and found incidentally during routine testing for something else. These masses are not cancerous and not even dangerous. Simple cysts of the ...

The Human Genome Project, launched in 1990 and completed in 2003, also moved the needle. Scientists had successfully ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with the Italian Medicines Agency (AIFA) for eligible transfusion-dependent beta thalassemia (TDT) and severe sickle ...

Motorists struggling with one of 188 medical conditions must inform the DVLA or risk facing fines of up to £1,000. Those ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Looking at options history for Vertex Pharmaceuticals (NASDAQ: VRTX) we detected 10 trades. If we consider the specifics of ...